Clinical characteristics, treatment, and outcomes of Oxaliplatin-induced immune thrombocytopenia - Top-Institutions - MDSpire

Clinical characteristics, treatment, and outcomes of Oxaliplatin-induced immune thrombocytopenia

  • By

  • Nan Huang

  • Zheng Liu

  • Ronghui Li

  • Haibo Lei

  • Xiang Liu

  • May 14, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mass General Brigham Cancer Institute
    Mass General Brigham Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology

  • #2

    Montpellier Cancer Institute
    Montpellier Cancer Institute

    Montpellier, Occitanie

    Key Differentiators

    • Oncology

  • #3

    University of Nebraska Medical Center
    University of Nebraska Medical Center

    Omaha, NE

    Key Differentiators

    • Hematology

  • #4

    German High-Grade Non-Hodgkin Lymphoma Study Group
    German High-Grade Non-Hodgkin Lymphoma Study Group

    N/A, N/A

    Key Differentiators

    • Hematology

  • #5

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Hematology-Oncology

Original Source(s)

Clinical characteristics, treatment, and outcomes of Oxaliplatin-induced immune thrombocytopenia

  • by Nan Huang, Zheng Liu, Ronghui Li, Haibo Lei, Xiang Liu

  • May 14, 2026

Related Content

Leveraging Text Messaging and Behavior Theory to Improve Colorectal Cancer Screening in Federally Qualified Health Centers: Cohort Study

The right hemicolon fascial system: a narrative review

Dye-free versus dye-containing submucosal injection solutions in ESD for colorectal LST: a multi-center retrospective study on efficacy and safety